Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-26 @ 4:15 PM
Study NCT ID:
NCT06831734
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-08-29
First Post:
2025-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2031-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-12
First Submit QC Date:
None
Study First Post Date:
2025-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-28
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED